Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01501877 · ClinicalTrials.gov registry record · NA
Smoking Cessation Intervention for Diabetic Patients
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01501877: Completed NA study, sponsored by Rhode Island Hospital.
NCT01501877 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01501877, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is designed to develop and test a smoking cessation intervention for smokers with Type 2 diabetes.
Primary Outcome
We will compare the percentage of participants in each treatment condition who report abstinence from smoking for the 7 days preceding the assessment.
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy
- BEHAVIORAL Standard smoking cessation intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-12 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT01501877 record still lists
NCT01501877 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.
NCT01501877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01501877 about?
NCT01501877 is a clinical study titled "Smoking Cessation Intervention for Diabetic Patients". This study is designed to develop and test a smoking cessation intervention for smokers with Type 2 diabetes.
What is the current status of trial NCT01501877?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-12. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01501877?
The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Standard smoking cessation intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01501877?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01501877's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia